{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-194481","form_type":"8-K","ticker":"KYMR","cik":"0001815442","company_name":"Kymera Therapeutics, Inc.","filed_at":"2025-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.091830+00:00","generated_at":"2026-05-17T08:37:35.502465+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Kymera Therapeutics appoints Brian Adams as Chief Legal Officer; Ellen Chiniara retires","bullets":["Ellen Chiniara, Chief Legal Officer, retires effective Sept 3, 2025; departure not due to any disagreement with the company.","Brian Adams appointed Chief Legal Officer and Corporate Secretary, effective Sept 3, 2025.","Adams previously served as CLO of Relay Therapeutics and held senior legal roles at Keryx, Algeta, AVEO, and Genzyme.","Chiniara receives no severance; she will focus on board service and mentoring."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-194481","json":"https://secwatch.observer/filing/0001193125-25-194481.json","markdown":"https://secwatch.observer/filing/0001193125-25-194481.md","text":"https://secwatch.observer/filing/0001193125-25-194481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525194481/0001193125-25-194481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525194481/d94060d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:37:35.502465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}